Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Chester

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Immunotechnology : an International Journal of Immunological Engineering|February 1, 1996
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion proteinN P Michael, K A Chester, R G Melton, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancerK A Chester, A Mayer, J Bhatia, et al.
The Biochemical Journal|March 24, 2000
Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contactsM K Boehm, A L Corper, T Wan, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Use of second antibody in radioimmunotherapyR H Begent, K D Bagshawe, R B Pedley, et al.
Disease Markers|May 22, 2001
Clinical applications of phage-derived sFvs and sFv fusion proteinsK A Chester, J Bhatia, G Boxer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2007
From laboratory to Phase I/II cancer trials with recombinant biotherapeuticsB Tolner, L Smith, T Hillyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibodyA Mayer, E Tsiompanou, D O'Malley, et al.
Nature Medicine|September 1, 1996
Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial libraryR H Begent, M J Verhaar, K A Chester, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Immunotechnology : an International Journal of Immunological Engineering|February 1, 1996
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion proteinN P Michael, K A Chester, R G Melton, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancerK A Chester, A Mayer, J Bhatia, et al.
The Biochemical Journal|March 24, 2000
Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contactsM K Boehm, A L Corper, T Wan, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Use of second antibody in radioimmunotherapyR H Begent, K D Bagshawe, R B Pedley, et al.
Disease Markers|May 22, 2001
Clinical applications of phage-derived sFvs and sFv fusion proteinsK A Chester, J Bhatia, G Boxer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2007
From laboratory to Phase I/II cancer trials with recombinant biotherapeuticsB Tolner, L Smith, T Hillyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibodyA Mayer, E Tsiompanou, D O'Malley, et al.
Nature Medicine|September 1, 1996
Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial libraryR H Begent, M J Verhaar, K A Chester, et al.
Pageof 4